BOM BOM produces algorithmically formulated, NRC-compliant portioned meals for cats and dogs sold via a direct-to-consumer model. The company serves a fast-growing client base in Singapore and Korea and offers customised meals that can eliminate the need for supplementation. Its products have reportedly helped pets resolve chronic health issues. BOM BOM combines precision pet nutrition with nutrigenomic research to tailor diets. The company plans to use the new funding to automate production, advance its nutrigenomic capabilities, and further enhance its platform. Founded in 2017, BOM BOM focuses on scaling operations while maintaining nutrition standards.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Sep 2025